1. Home
  2. HNVR vs KROS Comparison

HNVR vs KROS Comparison

Compare HNVR & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$26.43

Market Cap

191.4M

Sector

Finance

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.21

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
KROS
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
206.0M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
HNVR
KROS
Price
$26.43
$11.21
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$24.50
$21.86
AVG Volume (30 Days)
29.2K
159.9K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
146.00
EPS
0.80
N/A
Revenue
N/A
$243,864,000.00
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
$2,751.79
P/E Ratio
$33.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$9.69
52 Week High
$27.94
$22.55

Technical Indicators

Market Signals
Indicator
HNVR
KROS
Relative Strength Index (RSI) 45.96 52.28
Support Level $26.41 $10.57
Resistance Level $27.89 $11.61
Average True Range (ATR) 0.70 0.41
MACD -0.13 -0.02
Stochastic Oscillator 15.79 42.86

Price Performance

Historical Comparison
HNVR
KROS

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: